제약 약물 전달 시장 조사 – 규모, 점유율, 개발 및 미래 범위 2031

  • Report Code : TIPRE00007628
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 197
Buy Now

의약품 전달 시장은 2019년 US$ 1,403,082.9Mn에서 2027년 US$ 2,296,170.9Mn에 이를 것으로 예상됩니다. 시장은 2020년–2027년 동안 연평균 성장률(CAGR) 6.6%로 성장할 것으로 예상됩니다. .

약물 전달 시스템은 다양한 질병을 치료하거나 환자의 건강을 개선하기 위해 다양한 치료제를 제어 또는 표적 전달하는 데 주로 사용되는 기술입니다. 약물 전달 시스템은 약물이나 화학 물질을 신체에 주입하는 데 사용되는 의료 기기입니다. 시중에서 판매되는 일부 약물 전달 시스템에는 경점막, 경구, 폐, 주사, 국소, 비강, 이식형 및 안구 전달 시스템이 포함됩니다.

의약품 전달을 위한 수익성이 좋은 지역 시장

시장 통찰력

전염성 및 만성 질환의 유병률 증가

감염성 질병, 특히 세균성 질병의 유병률은 전 세계적으로 지속적으로 증가하고 있습니다. 2019년 미국 미생물학회에서 발표한 연구에 따르면 전 세계적으로 매년 카바페넴 내성 장내세균에 의해 약 150만 ~ 450만 건의 감염이 발생한다고 보고됩니다. 또한 이 박테리아 그룹으로 인해 미국에서는 매년 약 49,000명이 입원하게 됩니다. 또한 유니세프(UNICEF)가 발표한 연구에 따르면 2018년 폐렴으로 인해 5세 미만 어린이 1,755,000명이 사망했습니다. 또한 약 1,200,000명의 어린이가 설사로 목숨을 잃었습니다. 이러한 기하급수적으로 증가하는 감염병 유병률은 약물 소비를 촉진하고, 이는 결국 의약품 전달 시장 성장을 주도합니다.

만성 질환 중 암과 당뇨병은 질병의 주요 원인입니다. 전 세계적으로 사망률. 예를 들어, 미국 암학회(ACS)가 실시한 연구에 따르면 미국에서는 2018년에 약 1,735,350건의 새로운 암 사례가 보고되었습니다. 또한 국제 당뇨병 연맹(IDF)에 따르면 2017년에 약 4,600만 명의 미국인이 당뇨병을 앓고 있었습니다. , 이 수치는 2045년까지 6,200만 명에 이를 것으로 예상됩니다. 또한 2017년에는 전 세계적으로 약 4억 2,500만 명이 당뇨병을 앓고 있으며 2045년에는 그 수가 6억 2,900만 명에 이를 것으로 예상된다고 언급했습니다.

투여 경로 통찰력

의약품 전달 시장은 투여 경로에 따라 경구 약물 전달, 주사용 약물 전달, 국소 약물 전달, 안구 약물 전달, 폐 약물 전달, 비강 약물 전달, 경점막 약물 전달 및 이식형 약물 전달. 주사제 약물 전달 부문은 2019년 시장에서 가장 큰 점유율을 차지했습니다. 그러나 국소 약물 전달 부문은 예측 기간 동안 시장에서 가장 높은 CAGR을 기록할 것으로 예상됩니다.

투여 경로별 의약품 전달 시장 – 2019년 및 2027년

Applications Insights

애플리케이션을 기준으로 의약품 전달 시장은 전염병, 암, 심혈관 질환, 당뇨병으로 분류되었습니다. , 호흡기 질환, 중추 신경계 질환, 자가 면역 질환 및 기타 질병. 암 부문은 2019년 시장에서 가장 큰 점유율을 차지했습니다. 그러나 전염병 부문은 예측 기간 동안 가장 높은 CAGR을 기록할 것으로 추정됩니다.

최종 사용자 통찰력

최종 사용자 기준 , 의약품 전달 시장은 병원, 홈 케어 환경, ASC/클리닉 및 기타 최종 사용자로 분류되었습니다. 병원 부문은 2019년 시장에서 가장 큰 점유율을 차지한 반면, 홈 케어 설정 부문은 2020~2027년 동안 가장 높은 CAGR을 기록할 것으로 예상됩니다.

전략적 통찰력< /h3>

제품 출시 및 승인은 기업이 전 세계적으로 입지를 확장하고 증가하는 수요를 충족하기 위해 일반적으로 채택하는 전략입니다. 이 전략은 시장 참여자가 해당 제품 포트폴리오를 확장하기 위해 가장 일반적으로 채택합니다.

의약품 전달 시장에서 활동하는 플레이어는 고객 기반을 확대하기 위해 확장 전략을 채택합니다. 온 세계에; 또한 협업 및 제품 출시 전략을 구현합니다. 이러한 전략을 통해 전 세계적으로 브랜드 이름을 유지할 수 있습니다. 예를 들어, 2018년 5월 GlaxoSmithKline plc는 5세 미만 어린이의 천식 유지 치료를 위한 Arnuity Ellipta(플루티카손 푸로에이트) 사용에 대해 FDA 승인을 받았습니다. 하루 1회 흡입 코르티코스테로이드(ICS) 약입니다.

투여 경로에 따라

  • 경구 약물 전달
  • 주사 약물 전달
  • 국소 약물 전달
  • 안구 약물 전달
  • 폐 약물 전달
  • 비강 약물 전달
  • 경점막 약물 전달
  • 이식형 약물 전달

응용 분야별

  • 전염병
  • 암< /li>
  • 심장혈관 질환
  • 당뇨병
  • 호흡기 질환
  • 중추신경계 장애
  • 자가면역 질환
  • < li>기타 애플리케이션

최종 사용자별

  • 병원
  • 홈 케어 설정
  • ASC/클리닉< /li>
  • 기타 최종 사용자

지역별

  • 북미
    • 미국
    • 캐나다< /li>
    • 멕시코
  • 유럽
    • 독일
    • 영국
    • 프랑스
    • 이탈리아
    • 스페인
  • 아시아 태평양(APAC)
    • 중국
    • 인도
    • 일본
    • 대한민국
    • 호주
  • 중동 및 아프리카(MEA)
    • 남아프리카
    • 사우디아라비아
    • UAE
  • 중남미(SCAM)
    • 브라질
    • 아르헨티나

회사 프로필

  • Pfizer Inc.
  • Bayer AG
  • 존슨 & Johnson Services, Inc.
  • Novartis AG
  • 3M
  • Becton, Dickinson and Company
  • Sanofi
  • Merck KGaA
  • GlaxoSmithKline plc.
  • 안타레스 파마
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What does pharmaceutical drug delivery mean?

Drug delivery systems are medical devices used to inject drugs or chemicals into the body. Some of the drug delivery systems available in the market include, transmucosal, oral, pulmonary, injectable, topical, nasal, implantable, and ocular among others. Drug delivery systems are the technologies primarily used for the controlled or targeted delivery of various therapeutic agents to treat various diseases or improve the health of the patients.

What are the driving and restraining factors for the pharmaceutical drug delivery market across the globe?

The growth of the market is attributed to some key driving factors such as growing prevalence of infectious and increasing r&d spending for drug delivery devices. However, high cost of drug delivery device development is likely to pose a negative impact on the market during the forecast years.

What is the regional analysis in terms of pharmaceutical drug delivery?

The North American region holds the largest market for the pharmaceutical drug delivery. The United States held the largest market for pharmaceutical drug delivery mean market and is expected to grow due to factors such as increasing incidence of cancer along with the growing need for diagnosing, demand for chronic disease medications from pharmaceutical companies, presence of key market players and extensive R&D conducted by various academic and research institutes.

The List of Companies - Pharmaceutical Drug Delivery Market

  1. Pfizer Inc.
  2. Bayer AG
  3. Johnson & Johnson Services, Inc.
  4. Novartis AG
  5. 3M
  6. Becton, Dickinson and Company
  7. Sanofi
  8. MERCK KGaA
  9. GlaxoSmithKline plc.
  10. Antares Pharma

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports